The beat and guidance raise are positive catalysts, but underlying weakness in membership and margins suggests caution. Monitor medical cost trends and membership retention in upcoming quarters; the raised cash flow guidance supports capital returns.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 15 $390.33entry
- T+1 · 4mo ago −4.48%α −3.94% · $372.85
- T+5 · 4mo ago −0.32%α +0.66% · $389.09
- T+20 · 3mo ago +2.26%α −0.09% · $399.14
- T+60 · 6w ago +2.72%α +0.19% · $400.94
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Elevance Health reported Q2 2026 adjusted EPS of $7.45, a 20% beat vs consensus of $6.21, and raised full-year adjusted EPS guidance to at least $27.00. Operating revenue grew just 0.8% YoY to $49.8B, while GAAP EPS fell 13.1% and adjusted EPS fell 15.7% YoY, with benefit expense ratio rising 80bp to 89.7% and operating margin compressing to 3.5%. The beat and guidance raise are positive, but declining membership and margin pressure temper the outlook.
Key Financial Metrics
Key Facts
- Q2 2026 adjusted EPS $7.45 vs consensus $6.21 (beat by 20.0%)
- Q2 2026 operating revenue $49.8B vs consensus $48.63B (beat by 2.4%)
- FY2026 adjusted EPS guidance raised to at least $27.00 (from at least $26.75)
- FY2026 GAAP EPS guidance raised to at least $20.10 (from at least $19.85)
- FY2026 operating cash flow guidance raised to at least $6.0B (from at least $5.5B)
- Benefit expense ratio 89.7%, up 80bp YoY
- Health Benefits segment operating gain down 42.6% YoY
- Medical membership down 1.5% YoY and 1.0% sequentially
- Repurchased 0.7M shares for $234M in Q2
Financial Impact
Adjusted EPS beat consensus by $1.24 (20%); revenue beat by $1.2B (2.4%). Guidance raise adds ~$0.25 to adjusted EPS floor.
Risk Factors
- Elevated medical cost trend in Government businesses (Medicare, Medicaid)
- Membership declines in Medicare Advantage, Medicaid, and Employer Group risk
- CMS regulatory risk and potential financial exposure from historical risk adjustment data
- Operating margin compression from targeted investments and higher benefit expense
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001156039-26-000058 |
| Document: elv-20260715.htm | 0001156039-26-000058 |
| Document: 0001156039-26-000058-index-headers.html | 0001156039-26-000058 |
| Document: 0001156039-26-000058-index.html | 0001156039-26-000058 |
| Document: 0001156039-26-000058.txt | 0001156039-26-000058 |
| 8-K Data (Synthetic) | 0001156039-26-000058 |
Track record
19 reports on ELV
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.93% at T+5 after the Aug 27, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 2/10 Entry $429.48 Now $446.28 +3.91% settles Nov 18
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $425.62 to $429.69 Now $446.28 +4.85% ▲ +0.96% −1.64% vs SPY
- Oct 28, 202619d ago S-3ASR Neutral 3/10 Entry $422.02 to $432.00 Now $446.28 +5.75% ▲ +2.36% +7.09% vs SPY
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $439.95 to $420.07 Now $446.28 +1.44% ▼ −4.52% −3.96% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Sep 10, 20269w ago 8-K Neutral 3/10 Entry $416.54 to $414.26 Now $446.28 +7.14% ▼ −0.55% −0.05% vs SPY
- Aug 27, 202611w ago Institutional Cluster Bullish 6/10 Entry $399.11 to $414.78 Now $446.28 +11.82% ▲ +3.93% +3.66% vs SPY
- Aug 20, 202612w ago Court Ruling Neutral 2/10 Entry $400.54 to $394.43 Now $446.28 +11.42% ▼ −1.53% −2.00% vs SPY
- Aug 17, 202613w ago Court Ruling Neutral 1/10 Entry $396.54 to $397.14 Now $446.28 +12.54% ▲ +0.15% +0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers